Rosacea. Clinical features, pathogenesis and therapy;Rosazea. Klinik, pathogenese, therapie

Hautarzt

Volumn 56, Issue 9, 2005, Pages 871-887

  Lehmann, P ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Chronic inflammatory response; Dermal vessel and connective tissue damage; Skin types I ans II; Systemic treatment; Topical treatment

Indexed keywords

ADAPALENE; AMPICILLIN; ANTIFUNGAL AGENT; ANTIMALARIAL AGENT; AZELAIC ACID; CHLORAMPHENICOL; CLARITHROMYCIN; CLINDAMYCIN; CLONIDINE; COTRIMOXAZOLE; CYPROTERONE ACETATE; DAPSONE; DOXYCYCLINE; ERYTHROMYCIN; ISOTRETINOIN; METROCREME; METROLOTION; METRONIDAZOLE; MINOCYCLINE; NADOLOL; OXYTETRACYCLINE; PREDNISOLONE; RETINOID; SPIRONOLACTONE; TETRACYCLINE;

CARBON DIOXIDE LASER; CHRONIC INFLAMMATION; CLINICAL FEATURE; CLINICAL TRIAL; CONNECTIVE TISSUE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FLUSHING; HUMAN; NONVERBAL COMMUNICATION; PAPULAR SKIN DISEASE; PATHOGENESIS; PHENOTYPE; PSYCHOLOGICAL ASPECT; PUSTULE; REVIEW; ROSACEA; ROSACEA CONGLOBATA; ROSACEA FULMINANS; SEASONAL VARIATION; SKIN ABRASION; SKIN BLOOD VESSEL; SKIN DISEASE; SKIN NODULE; SOCIAL INTERACTION; TELANGIECTASIA; TREATMENT OUTCOME; YAG LASER;

ANTI-BACTERIAL AGENTS; DERMATOLOGIC AGENTS; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; ROSACEA;

EID: 24044469664     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-005-1009-3     Document Type: Review

References (16)

1. Brinnel H, Friedel J, Caputa M et al. (1989) Rosacea: disturbed defense against brain overheating. Arch Dermatol Res 281:66-72
2. Crawford GH, Pelle MT, James WD (2004) Rosacea. I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 51:327-341
3. Czernielewski J, Liu Y (2004) Comparison of 15% azelaic acid gel and 0,75% metronidazole gel for the topical treatment of papulopustular rosacea
4. Dahl MV, Katz I, Krueger GG et al. (1998) Topical metronidazole maintains remissions of rosacea. Arch Dermatol 134:679-683
5. Greaves MW, Burova E (1997) Flushing: causes, investigation and clinical consequences. J Eur Acad Dermatol Venereol 8:91-100
6. Hölzle E, Jansen T, Plewig G (1995) Morbus Morbihan - Chronisch persistierendes Ödem des Gesichtes. Hautarzt 46:796-798
7. Jansen T, Melnik B, Plewig G (1994) Gramnegative Follikulitis als Begleitkomplikation bei Rosazea. Akt Dermatol 20:381-384
8. Lehmann P, Arens A (2000) Rosacea fulminans. In: Plettenberg A, Meigel WN, Moll I (Hrsg) Dermatologie an der Schwelle zum neuen Jahrtausend. Springer, Berlin Heidelberg New York Tokyo, S 257-259
9. Lehmann P (2003) Klinische Studien zur topischen Therapie mit Metronidazol bei Rosazea: Rosazea - Klinik und aktuelle Therapie S 41-50 67.
10. Mauss J (1981) Behandlung der papulopustulösen Rosazea der Frau mit Zyproteronacetat. Hautarzt 32:94-95
11. O'Leary PA, Kierland RR (1940) Pyoderma faciale. Arch Dermatol 41:451-462
12. Pelle MT, Crawford GH, James WD (2004) Rosacea. II. Therapy. J Am Acad Dermatol 51:499-512
13. Plewig G, Kligman AM (2000) Acne and Rosacea, 3rd edn. Springer, Berlin Heidelberg New York Tokyo, p 365
14. Powell FC (2005) Clinical practice. Rosacea. N Engl J Med 352:795-803
15. Schöfer H (2003) Rosazea: Klinik und aktuelle Therapie. Georg Thieme, Stuttgart New York
16. Wilkin J, Dahl M, Detmar M et al. (2002) Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 45:584-587